Literature DB >> 11571320

Specificity of the fivefold increase in AD in mothers of adults with Down syndrome.

N Schupf1, D Kapell, B Nightingale, J H Lee, J Mohlenhoff, S Bewley, R Ottman, R Mayeux.   

Abstract

BACKGROUND: In a previous study, the authors found that the risk of AD among mothers who were 35 years or younger when their children with Down syndrome (DS) were born was five times that of mothers of children with other forms of mental retardation. The current study investigated the specificity of the familial aggregation of DS and AD by examining whether mothers who gave birth to children with DS before age 35 are also at increased risk of other age-related neurologic or medical disorders.
METHODS: The authors used survival methods to compare cumulative incidence and relative risk of AD, other dementias, and common age-related disorders in parents of 200 adults with DS and parents of 252 adults with other forms of mental retardation.
RESULTS: Mothers who were < or =35 years of age when their children with DS were born were four to five times as likely to develop AD as control mothers (rate ratio = 4.8, 95% CI 2.1, 11.2), whereas risk of AD among mothers who were >35 years when their children with DS were born was not significantly increased (rate ratio = 1.8, 95% CI 0.6, 5.1). Risk of AD among fathers of probands with DS was similar to that of control fathers, and did not vary by age at proband birth. Risk of other dementias and of other age-related medical condition was similar among mothers and fathers of probands with DS and control parents, regardless of age at proband birth.
CONCLUSION: These findings suggest that the increased risk of AD among mothers who gave birth to children with DS before age 35 appears to represent a specific vulnerability to AD, as opposed to other age-related degenerative disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11571320     DOI: 10.1212/wnl.57.6.979

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination.

Authors:  S E Peterson; J L Nelson; K A Guthrie; V K Gadi; T M Aydelotte; D J Oyer; S W Prager; H S Gammill
Journal:  Hum Reprod       Date:  2012-06-29       Impact factor: 6.918

2.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

Review 3.  The otherness of self: microchimerism in health and disease.

Authors:  J Lee Nelson
Journal:  Trends Immunol       Date:  2012-05-19       Impact factor: 16.687

4.  Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy.

Authors:  Debrah I Boeras; Antoneta Granic; Jaya Padmanabhan; Nichole C Crespo; Amyn M Rojiani; Huntington Potter
Journal:  Neurobiol Aging       Date:  2006-12-13       Impact factor: 4.673

Review 5.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

6.  One-carbon metabolism and Alzheimer's disease: focus on epigenetics.

Authors:  Fabio Coppedè
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

7.  Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.

Authors:  Disha Banerjee; Krishnadas Nandagopal
Journal:  Cell Mol Neurobiol       Date:  2007-09-28       Impact factor: 5.046

8.  Association of methylenetetrahydrofolate reductase gene 677C > T polymorphism and Down syndrome.

Authors:  Marcelo Aguiar Costa-Lima; Márcia Rodrigues Amorim; Iêda Maria Orioli
Journal:  Mol Biol Rep       Date:  2012-11-25       Impact factor: 2.316

9.  Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?

Authors:  Maj A Hultén; Jon Jonasson; Ann Nordgren; Erik Iwarsson
Journal:  Curr Genomics       Date:  2010-09       Impact factor: 2.236

Review 10.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.